SCHEMBL20652748

SCHEMBL20652748

CC(C)n1c(=O)[nH]c(=O)c2c1nc(-c1cccnc1OCC1CC1)n2Cc1cc(F)cc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HTT P42858 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ P2RX7 Q99572 1/20 0.36
▸ USP1 O94782 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX5AP P20292 2/20 0.35
▸ FEN1 P39748 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ FFAR4 Q5NUL3 2/20 0.34
▸ MDM2 Q00987 1/20 0.34
▸ BRDT Q58F21 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652960 0.93 TP53 (0.42) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20653129 0.91 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20652967 0.90 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20653050 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20652772 0.89 ALDH1A1 (0.41) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20653055 0.88 MDM2 (0.44) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20652951 0.82 FFAR4 (0.36) ALDH1A1HTTP2RX7USP1MAPT
SCHEMBL20656031 0.77 PKM (0.41) ALDH1A1KDM4EHTTSMN1; SMN2USP1
SCHEMBL20653046 0.77 KDM4E (0.49) ALDH1A1KDM4EKMT2AHTTMEN1
SCHEMBL20652749 0.74 KDM4E (0.41) ALDH1A1KDM4EKMT2ASMN1; SMN2ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 ALDH1A1 1347/4885KDM4E 3884/4885KMT2A 4180/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 ALDH1A1 1488/4885KDM4E 3789/4885KMT2A 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback